menu toggle

Medicare Part B: Do Providers Choose Treatment Based on Payment?

By AmerisourceBergen

The Medicare Part B program has been criticized as creating a financial incentive for physicians to prescribe more expensive drugs. An Xcenda study found no strong, positive correlation between drug payment and utilization.

Find Out More

Read the Medicare Part B Utilization Report to learn more about Xcenda's approach and findings.

Topics:
Policy Reimbursement

Related Content

Manufacturers

Webinar: the growing utilization of copay accumulator programs

Corey Ford
Corey Ford, MHA; Dale Hanna
December 2020
lash group copay accumulator program

Manufacturers

Gauge the impact: What does the striking down of a federal copay accumulator regulation mean for patients and copay programs?

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2023
US capitol color

Manufacturers

First 10 drugs for Medicare price negotiation announced under IRA

Corey Ford
Corey Ford, MHA
August 2023
Washington DC Capital